Where Data Tells the Story
© Voronoi 2026. All rights reserved.
This pie chart captures how Stanley Druckenmiller structured his Q4 2025 holdings, blending high‑conviction biotech names with tactical ETF exposure and selective global plays. Natera (12.8%) remains his largest position despite a reduction, while new allocations to XLF, RSP, and EWZ signal a shift toward liquidity, financial strength, and international diversification. Increases in Amazon, Coupang, Alphabet, Sea Ltd, and BBB Foods highlight a renewed appetite for growth where fundamentals are strengthening.
The druckenmiller portfolio reflects a macro‑aware strategy: protect capital, stay flexible, and size up only where conviction meets improving trends.
This snapshot shows a portfolio built for adaptability — leaning into strength, cutting weakness quickly, and staying aligned with macro currents heading into 2026.